Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
58.83
+0.43 (0.74%)
At close: Mar 23, 2026, 4:00 PM EDT
60.00
+1.17 (1.99%)
After-hours: Mar 23, 2026, 4:59 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $80.72 million as of March 23, 2026. Its market cap has increased by 443.76% in one year.
Market Cap
80.72M
Enterprise Value
37.35M
1-Year Change
443.76%
Ranking
Category
Stock Price
$58.83
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $80.72M, a decrease of -78.67%. That is a compound annual growth rate of -24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 80.13M | -14.06% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 84.62M |
| Impact BioMedical | 84.10M |
| Kazia Therapeutics | 81.50M |
| Seres Therapeutics | 81.48M |
| Champions Oncology | 81.38M |
| Biomea Fusion | 80.60M |
| Pliant Therapeutics | 79.87M |
| aTyr Pharma | 79.25M |